Jordi Esteve Reyner

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

David Bearss

UNITED STATES

View details

Iman Abou Dalle

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Abdul Hamid Bazarbachi

Columbia University Irving Medical Center

UNITED STATES

View details

Emmanuel GYAN

Professor of Hematology

Université de Tours Faculté de Médecine

FRANCE

View details

Jaime Sanz

Profesor asociado asistencial

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

Joshua Zeidner

Associate Professor of Medicine

University of North Carolina, Lineberger Comprehensive Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jordi Esteve Reyner

Research Interests

Explore related searches

Contact this professor

Articles (13)

Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia‐Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT

Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Improving the EASIX’ predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

Collaborators (6)

David Bearss

Iman Abou Dalle

Abdul Hamid Bazarbachi

Emmanuel GYAN

Jaime Sanz

Joshua Zeidner

Make your next move.